|
US3253023A
(en)
|
1963-09-27 |
1966-05-24 |
Dow Chemical Co |
Recovery of 3-(3, 4-dihydroxyphenyl)-l-alanine from velvet beans
|
|
BE759371A
(fr)
|
1969-11-24 |
1971-05-24 |
Bristol Myers Co |
Azaspirodecanediones heterocycliques et procedes pour leur preparation
|
|
US3976776A
(en)
|
1972-12-06 |
1976-08-24 |
Mead Johnson & Company |
Tranquilizer process employing N-(heteroarcyclic)piperazinylalkylazaspiroalkanediones
|
|
US4166452A
(en)
|
1976-05-03 |
1979-09-04 |
Generales Constantine D J Jr |
Apparatus for testing human responses to stimuli
|
|
US4182763A
(en)
|
1978-05-22 |
1980-01-08 |
Mead Johnson & Company |
Buspirone anti-anxiety method
|
|
US4356108A
(en)
|
1979-12-20 |
1982-10-26 |
The Mead Corporation |
Encapsulation process
|
|
US4265874A
(en)
|
1980-04-25 |
1981-05-05 |
Alza Corporation |
Method of delivering drug with aid of effervescent activity generated in environment of use
|
|
US4438119A
(en)
|
1982-12-23 |
1984-03-20 |
Mead Johnson & Company |
Method for alleviation of extrapyramidal motor disorders
|
|
US4640921A
(en)
|
1986-02-04 |
1987-02-03 |
Bristol-Myers |
Treatment of sexual dysfunction with buspirone
|
|
US4832957A
(en)
|
1987-12-11 |
1989-05-23 |
Merck & Co., Inc. |
Controlled release combination of carbidopa/levodopa
|
|
US4687772A
(en)
|
1986-10-07 |
1987-08-18 |
Bristol-Myers Company |
Method for improvement of short term memory
|
|
US4777173A
(en)
|
1987-03-25 |
1988-10-11 |
Bristol-Myers Company |
Method for treatment of alcohol abuse
|
|
US5185329A
(en)
|
1988-08-30 |
1993-02-09 |
Bristol-Myers Squibb Company |
Method for treatment of substance addiction
|
|
US6432956B1
(en)
|
1990-02-12 |
2002-08-13 |
William C. Dement |
Method for treatment of sleep apneas
|
|
CZ288351B6
(en)
|
1990-06-07 |
2001-05-16 |
Astrazeneca Ab |
Nitrogenous heterocyclic compound, process of its preparation and use as well as a medicament containing thereof
|
|
US5633009A
(en)
|
1990-11-28 |
1997-05-27 |
Sano Corporation |
Transdermal administration of azapirones
|
|
US5431922A
(en)
|
1991-03-05 |
1995-07-11 |
Bristol-Myers Squibb Company |
Method for administration of buspirone
|
|
DE4122217C2
(de)
|
1991-07-04 |
1997-02-13 |
Merz & Co Gmbh & Co |
Verfahren zur Herstellung mechanisch stabiler, gut zerfallender Komprimate aus kleinen wirkstoffhaltigen Formkörpern
|
|
GB9209882D0
(en)
|
1992-05-07 |
1992-06-24 |
Glaxo Lab Sa |
Compositions
|
|
US5484788A
(en)
|
1993-03-26 |
1996-01-16 |
Beth Israel Hospital Association |
Buspirone as a systemic immunosuppressant
|
|
US5637314A
(en)
|
1995-06-07 |
1997-06-10 |
Beth Israel Deaconess Medical Center, Inc. |
Topical and systemic application of buspirone or derivatives thereof for treating atopic dermatitis
|
|
GB9816556D0
(en)
|
1998-07-30 |
1998-09-30 |
Pfizer Ltd |
Therapy
|
|
US20080118556A1
(en)
*
|
1998-11-02 |
2008-05-22 |
Elan Corporation, Plc |
Modified Release of Compositions Containing a Combination of Carbidopa, Levodopa and Entacapone
|
|
FI109453B
(fi)
*
|
1999-06-30 |
2002-08-15 |
Orion Yhtymae Oyj |
Farmaseuttinen koostumus
|
|
US6150365A
(en)
|
1999-08-05 |
2000-11-21 |
Bristol-Myers Squibb Company |
Anxiety method
|
|
GB9928578D0
(en)
|
1999-12-03 |
2000-02-02 |
Zeneca Ltd |
Pharmaceutical formulations
|
|
US6627223B2
(en)
|
2000-02-11 |
2003-09-30 |
Eurand Pharmaceuticals Ltd. |
Timed pulsatile drug delivery systems
|
|
WO2002044159A2
(en)
|
2000-11-29 |
2002-06-06 |
Eli Lilly And Company |
1-(2-m-methanesulfonamidophenylethyl)-4-(m-trifluoromethylphenyl)piperazine and pharmaceutically acceptable salts and solvates thereof and their use in the treatment of incontinence
|
|
WO2002053139A2
(en)
|
2001-01-05 |
2002-07-11 |
Eli Lilly And Company |
Excitatory amino acid receptor antagonist and 5-ht1f agonist combination: a method for the treatment of neurological disorders
|
|
US20030035839A1
(en)
*
|
2001-05-15 |
2003-02-20 |
Peirce Management, Llc |
Pharmaceutical composition for both intraoral and oral administration
|
|
US8329734B2
(en)
|
2009-07-27 |
2012-12-11 |
Afgin Pharma Llc |
Topical therapy for migraine
|
|
BR0211317A
(pt)
|
2001-07-04 |
2004-12-14 |
Sun Pharmaceutical Ind Ltd |
Sistema para a liberação controlada de uma droga por meio de retenção gástrica
|
|
DE60211186T2
(de)
|
2001-09-19 |
2007-01-18 |
Merck Patent Gmbh |
Neue verwendung substituierter aminomethylchromane
|
|
KR20050016449A
(ko)
*
|
2002-05-29 |
2005-02-21 |
임팩스 라보라토리즈, 인코포레이티드 |
레보도파/카르비도파의 즉시 방출 및 제어 방출 조합 투여형
|
|
US7094427B2
(en)
|
2002-05-29 |
2006-08-22 |
Impax Laboratories, Inc. |
Combination immediate release controlled release levodopa/carbidopa dosage forms
|
|
US20030224045A1
(en)
*
|
2002-05-29 |
2003-12-04 |
Chien-Hsuan Han |
Combination immediate release sustained release levodopa/carbidopa dosage forms
|
|
CA2541382A1
(en)
|
2003-10-10 |
2005-04-21 |
Lifecycle Pharma A/S |
A solid dosage form comprising a fibrate and a statin
|
|
US7470435B2
(en)
|
2003-11-17 |
2008-12-30 |
Andrx Pharmaceuticals, Llc |
Extended release venlafaxine formulation
|
|
DE10353657A1
(de)
|
2003-11-17 |
2005-06-23 |
Merck Patent Gmbh |
Indolderivate
|
|
EP1711493A2
(en)
|
2004-02-06 |
2006-10-18 |
CIBA SPECIALTY CHEMICALS HOLDING INC. Patent Departement |
Crystalline forms of zolmitriptan
|
|
US20070155755A1
(en)
|
2004-02-23 |
2007-07-05 |
Wei Edward T |
N-arylshydroxyalkylidene-carboxamide compositions and methods
|
|
WO2006014427A1
(en)
|
2004-07-02 |
2006-02-09 |
Advancis Pharmaceutical Corporation |
Tablet for pulsed delivery
|
|
CA2578990A1
(en)
|
2004-09-07 |
2006-03-16 |
Pfizer Inc. |
Combination of a 5-ht(1) receptor agonist and an alpha-2-delta ligand for the treatment of migraine
|
|
EP2623099A1
(en)
*
|
2004-11-24 |
2013-08-07 |
Neuromolecular Pharmaceuticals, Inc |
Composition and method for treating neurological disease
|
|
EP1856100B1
(en)
|
2005-01-18 |
2010-05-05 |
Merck Sharp & Dohme Corp. |
Cgrp receptor antagonists
|
|
US20080166407A1
(en)
|
2005-07-29 |
2008-07-10 |
Shalaby Shalaby W |
Solid oral formulations for combination therapy
|
|
US9066903B2
(en)
|
2006-02-28 |
2015-06-30 |
The United States Of America As Represented By The Department Of Veterans Affairs |
Pharmacological treatment of Parkinson's disease
|
|
WO2007129329A2
(en)
|
2006-05-08 |
2007-11-15 |
Jubilant Organosys Limited |
Extended release pharmaceutical formulation comprising venlafaxine hydrochloride
|
|
US7678808B2
(en)
|
2006-05-09 |
2010-03-16 |
Braincells, Inc. |
5 HT receptor mediated neurogenesis
|
|
WO2007144422A2
(en)
|
2006-06-16 |
2007-12-21 |
Solvay Pharmaceuticals B.V. |
Combination preparations comprising bifeprunox and l-dopa
|
|
WO2008033155A1
(en)
|
2006-09-15 |
2008-03-20 |
Auriga Laboratories, Inc. |
Kits for prevention and treatment of rhinitis
|
|
WO2008047839A1
(en)
|
2006-10-19 |
2008-04-24 |
Dainippon Sumitomo Pharma Co., Ltd. |
5-ht1a receptor agonist
|
|
CA2673511A1
(en)
*
|
2006-12-22 |
2008-07-03 |
Combinatorx, Incorporated |
Pharmaceutical compositions for treatment of parkinson's disease and related disorders
|
|
EP1970056A1
(en)
*
|
2007-03-15 |
2008-09-17 |
Polichem S.A. |
Time-specific delayed/pulsatile release dosage forms
|
|
WO2008115797A1
(en)
|
2007-03-16 |
2008-09-25 |
Pavo, Inc. |
Therapeutic compositions and methods
|
|
CN101686942B
(zh)
|
2007-06-27 |
2012-09-26 |
韩美药品株式会社 |
用于快速制备用于口服的崩解剂的方法及其产品
|
|
NZ602302A
(en)
|
2007-12-28 |
2014-04-30 |
Impax Laboratories Inc |
Controlled release formulations of levodopa and uses thereof
|
|
KR101444979B1
(ko)
|
2008-02-06 |
2014-10-07 |
욱크하르트 리미티드 |
생체 이용율이 개선된 엔타카폰, 레보도파 및 카르비도파의 약학 조성물
|
|
EP2105130A1
(de)
|
2008-03-25 |
2009-09-30 |
Ratiopharm GmbH |
Pharmazeutische Formulierung und Verfahren zu deren Herstellung
|
|
DK2276473T3
(en)
|
2008-04-18 |
2017-01-09 |
Intec Pharma Ltd |
GASTRORETENTIV drug TO carbidopa / levodopa
|
|
WO2009156380A1
(en)
|
2008-06-24 |
2009-12-30 |
Bjoerklund Anders |
Eltoprazine for suppression of l-dopa induced dyskinesias
|
|
PT2361081T
(pt)
|
2008-10-14 |
2016-09-05 |
Mcneil Ab |
Forma de dosagem intra-oral multiporção e seu uso
|
|
EA026651B1
(ru)
|
2009-01-23 |
2017-05-31 |
Ацьенде Кимике Рьюните Анджелини Франческо А.К.Р.А.Ф. С.П.А. |
Фармацевтический или пищевой состав с контролируемым высвобождением и способ его получения
|
|
SG181896A1
(en)
|
2009-12-23 |
2012-07-30 |
Map Pharmaceuticals Inc |
Novel ergoline analogs
|
|
CN101987081B
(zh)
*
|
2010-07-16 |
2012-08-08 |
钟术光 |
一种控释制剂
|
|
CN103402514B
(zh)
|
2010-10-15 |
2016-01-13 |
康特拉医药公司 |
用于治疗运动障碍的血清素受体激动剂组合物
|
|
US20140017303A1
(en)
|
2010-11-01 |
2014-01-16 |
Intec Pharma Ltd. |
Accordion pill comprising levodopa for an improved treatment of parkinson's disease symptoms
|
|
WO2012163365A1
(en)
|
2011-06-01 |
2012-12-06 |
Concit Pharma Aps |
Combinations of serotonin receptor agonists for treatment of movement disorders
|
|
US20130195973A1
(en)
|
2012-01-30 |
2013-08-01 |
Ranbaxy Laboratories Limited |
Extended release pharmaceutical dosage forms of carbidopa and levodopa and process of preparation thereof
|
|
CA2973701A1
(en)
|
2015-01-13 |
2016-07-21 |
Amarantus Bioscience Holdings, Inc. |
Methods of treating motor and movement disorders and side effects thereof associated with parkinson's disease treatments
|
|
CN109689036B
(zh)
*
|
2016-07-11 |
2026-06-19 |
康特拉医药股份有限公司 |
用于治疗早晨运动不能的脉冲药物输送系统
|